When will Americans be able to shop for care?

The latest stories trending on MedCity News.

Editor's Pick

Top Story Despite Price Transparency Laws, Americans Are Nowhere Near Able to Shop for Care. How Can This Change? Most hospitals and payers have publicly posted their pricing information, but experts think that data will remain mostly useless for consumers for at least another five years. Now that the data is available, healthcare software companies must step in and build tools that are personalized and easy to use. That way, consumers can eventually use price transparency data to shop for care. Sponsored Content Improve Consumer Experience and Fuel Growth Presented by AVIA Health Health Systems face significant technical barriers in their ability to provide patients with efficient individually personalized care.  This webinar will feature expert panelists from Praia Health and Providence who will highlight the changes needed to harness the right technology to create an effective solution. Hurry, 1 Day Left to Save on INVEST 2024 Super Early Bird Pricing for INVEST 2024 ends Friday night. This is your chance to connect with the best minds in healthcare and investing at the Ritz in Chicago. Don't miss out on the premier healthcare networking event of the year. Register Now

Featured News

Are You a Healthcare Startup Looking for Investors? Sign Up for MedCity's Pitch Perfect Contest! The event will take place in Chicago at the Ritz Carlton from May 21-22. The startup tracks include: oncology, cardiology, women's health and preventing burnout/supporting operational efficiency. The deadline to submit applications is February 29 so apply today! Episode 1: Debunked (audio): Slaughtering Myths, Bad Practices and Sacred Cows in Healthcare Here's the audio of Episode 1 of the newly-launched show Debunked: Slaughtering Myths, Bad Practices and Sacred Cows in Healthcare. Omada Expands GLP-1 Care Track To Include Exercise Plans, Member Level Reporting Omada's newly expanded GLP-1 Care Track provides tailored exercise plans, support for getting off of GLP-1s and calorie tracking. It also offers insight into who is responding to GLP-1s and who is engaging in Omada's program. FDA Approves New First-Line Med for Pancreatic Cancer as Drug's Initial Developer Dissolves Ipsen's Onivyde is now FDA approved as a first-line treatment for metastatic pancreatic cancer, triggering a milestone payment to Merrimack Pharmaceuticals, the drug's original developer. Merrimack plans to dissolve operations but its shareholders will receive payouts from the Ipsen payment. Top 5 Strategic Focus Areas for Global Pharma Marketers in 2024 2024 presents an exciting yet challenging landscape for global pharma marketers. Prioritizing digital transformation, adopting patient-centric strategies, navigating regulatory complexities, investing in innovative content marketing, and fostering global collaboration position pharmaceutical marketers to make a lasting impact in an ever-evolving industry. From Buzzword to Action: Addressing SDOH to Advance Health Equity When striving for health equity, organizations need to adopt new methods and a new mindset in order to steer clear of using SDoH as a buzzword, and instead hit the mark of health equity results. Downside of One-Size-Fits-All: Rethinking Weight-Loss Medications Strategy A comprehensive approach to obesity management goes beyond prescribing medications for a quick fix.

Resources

Recent Hires, Layoffs & an Interview with Kristin Myers, Chief Digital Officer at Northwell Health In this episode of The MedCity Moves Podcast, Senior Reporter Katie Adams chats with Kristin Myers, who recently became Northwell Health's first chief digital officer. Listen to learn more about Myers' career journey and what her goals are for her new organization. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe